Effects of Omalizumab in Non-Atopic Asthma: Results from a Spanish Multicenter Registry-Reference-Cited by-同舟云学术

Effects of Omalizumab in Non-Atopic Asthma: Results from a Spanish Multicenter Registry

Published:2013-01-28 Issue:3 Volume:50 Page:296-301
ISSN:0277-0903
Container-title:Journal of Asthma
language:en
Short-container-title:Journal of Asthma

Author:

de Llano Luis Pérez,Vennera María del Carmen,Álvarez Francisco J.,Medina Juan F,Borderías Luis,Pellicer Concha,González Héctor,Gullón José A,Martínez-Moragón Eva,Sabadell Carlos,Zamarro Soledad,Picado César,

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference18 articles.

1. Severe asthma: Lessons from the Severe Asthma Research Program

2. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program

3. Severity assessment in asthma: An evolving concept

4. Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program

5. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of a proposed omalizumab biosimilar compared to the reference product in the management of uncontrolled moderate-to-severe allergic asthma: a multicenter, phase III, randomized, double-blind, equivalency clinical trial;Frontiers in Immunology;2024-07-29

2. Factors influencing poor response to type 2 targeted therapies in severe asthma: a retrospective cohort study;BMC Pulmonary Medicine;2023-12-05

3. Real-life studies and registries of severe asthma: The advent of digital technology;Respiratory Medicine;2023-12

4. Unanswered questions on the use of biologics in pediatric asthma;World Allergy Organization Journal;2023-11

5. Can omalizumab be an alternative treatment for non-atopic severe asthma? A real-life experience with omalizumab;Tuberk Toraks;2023-03-10